Moleculin Biotech Inc. logo

Moleculin Biotech Inc. (MBRX)

Market Open
15 Jun, 17:21
NASDAQ (CM) NASDAQ (CM)
$
2. 70
+0.06
+2.2727%
$
13.34M Market Cap
- P/E Ratio
- Div Yield
56,913 Volume
-0.87 Eps
$ 2.64
Previous Close
Investors:
Add Transaction
Day Range
2.65 2.75
Year Range
1.79 24
Want to track MBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
11 May 2026
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
20 Mar 2026
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
17 Nov 2025
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
12 Aug 2025
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
8 May 2025
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
20 Mar 2025
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
11 Nov 2024
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
9 Aug 2024
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
14 Jun 2024
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
20 Mar 2024
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
8 Nov 2023
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
21 Nov 2016
-
-
Moleculin Biotech Inc. logo
MBRX Moleculin Biotech Inc.
15 Aug 2016
-
-

MBRX Earnings Reports FAQ

What is the earnings per share (EPS) for MBRX?

The current EPS is -0.87.

What is the company's earnings growth rate?

Moleculin Biotech Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Moleculin Biotech Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Moleculin Biotech Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for MBRX at this time, as Moleculin Biotech Inc has no recent EPS data to calculate it.